Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

Total Articles

5
(from Reference Citation Analysis)

Article PDFs (0)

Cited by > 0 (2)

Searched Name

Gustavo JS Pereira

Ranked By

Results Analysis

Year Published Analysis
Article Type Analysis
Publication Title Analysis
Category Analysis

Results Analysis

Indexed Articles

Year Published

Show more Refine

Article Statistics

Refine

Publication Titles

Show more Refine

Grant Agencies

Show more Refine

Category

Show more Refine

Number	Citation Analysis
1	DEVELOPMENT OF SCAFFOLD-FREE SPHEROIDS OVEREXPRESSING ALPHA-SYNUCLEIN IN HUMAN NEUROBLASTOMA SH-SY5Y AS A MODEL OF PARKINSON'S DISEASE. Cytotherapy 2021. [DOI: 10.1016/j.jcyt.2021.02.035] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Abstract Collapse Key Words Collapse MESH Headings Collapse Grants Collapse
2	Nutritional shortage augments cisplatin-effects on murine melanoma cells. Chem Biol Interact 2017;281:89-97. [PMID: 29273566 DOI: 10.1016/j.cbi.2017.12.027] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/26/2017] [Revised: 11/25/2017] [Accepted: 12/18/2017] [Indexed: 01/06/2023] Abstract Melanoma incidence increases every year worldwide and is responsible for 80% of skin cancer deaths. Due to its metastatic potential and resistance to almost any treatments such as chemo, radio, immune and targeted-therapy, the patients still have a poor prognosis, especially at metastatic stage. Considering that, it is crucial to find new therapeutic approaches to overcome melanoma resistance. Here we investigated the effect of cisplatin (CDDP), one of the chemotherapeutic agents used for melanoma treatment, in association with nutritional deprivation in murine melanoma cell lines. Cell death and autophagy were evaluated after the treatment with cisplatin, nutritional deprivation and its association using an in vitro model of murine melanocytes malignant transformation to metastatic melanoma. Our results showed that nutritional deprivation augmented cell death induced by cisplatin in melanoma cells, especially at the metastatic subtype, with slight effects on melanocytes. Mechanistic studies revealed that although autophagy was present at high levels in basal conditions in melanoma cells, was not essential for cell death process that involved mitochondrial damage, reactive oxygen species production and possible glycolysis inhibition. In conclusion, nutritional shortage in combination with chemotherapeutic drugs as cisplatin can be a valuable new therapeutic strategy to overcome melanoma resistance. Collapse Key Words Autophagy Chemosensitization Cisplatin Melanoma Nutrient deprivation Starvation Collapse MESH Headings Collapse Grants Collapse
3	Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy 2016;12:1-222. [PMID: 26799652 PMCID: PMC4835977 DOI: 10.1080/15548627.2015.1100356] [Citation(s) in RCA: 4041] [Impact Index Per Article: 505.1] [Reference Citation Analysis] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/22/2015] [Accepted: 09/22/2015] [Indexed: 12/09/2022] Open Abstract Collapse Key Words LC3 autolysosome autophagosome chaperone-mediated autophagy flux lysosome macroautophagy phagophore stress vacuole Collapse MESH Headings Animals Autophagy/physiology Biological Assay/methods Biological Assay/standards Computer Simulation Humans Collapse Grants R01 GM116908 NIGMS NIH HHS I01 BX001110 BLRD VA R01 CA078810 NCI NIH HHS R15 AI089518 NIAID NIH HHS R03 DK092434 NIDDK NIH HHS R01 EY026171 NEI NIH HHS I01 BX000976 BLRD VA R01 CA187305 NCI NIH HHS R01 AI091968 NIAID NIH HHS R01 NS078072 NINDS NIH HHS R01 HL126711 NHLBI NIH HHS R01 EY010199 NEI NIH HHS R01 DK044234 NIDDK NIH HHS R01 AR050429 NIAMS NIH HHS R01 HL072844 NHLBI NIH HHS MC_UU_12016/4 Medical Research Council R01 DK083575 NIDDK NIH HHS P20 RR024489 NCRR NIH HHS R21 AI115286 NIAID NIH HHS 11359 Cancer Research UK 13101 Cancer Research UK MC_UP_A390_1106 Medical Research Council K08 DK089117 NIDDK NIH HHS R01 GM021841 NIGMS NIH HHS P30 CA016672 NCI NIH HHS R01 NS065789 NINDS NIH HHS R01 AI103197 NIAID NIH HHS R01 CA159314 NCI NIH HHS R56 DK108921 NIDDK NIH HHS R01 CA140964 NCI NIH HHS R01 AI087669 NIAID NIH HHS MR/J010448/1 Medical Research Council R01 CA132136 NCI NIH HHS R01 EY024327 NEI NIH HHS MC_U132670600 Medical Research Council 145505 Swiss National Science Foundation R01 DK097441 NIDDK NIH HHS I01 BX001969 BLRD VA R03 DK106304 NIDDK NIH HHS R01 EY018884 NEI NIH HHS G0300648 Medical Research Council U54 CA149147 NCI NIH HHS R01 NS069566 NINDS NIH HHS R01 AG032611 NIA NIH HHS R01 DK076685 NIDDK NIH HHS R01 AG039756 NIA NIH HHS R01 CA138441 NCI NIH HHS U01 DK127747 NIDDK NIH HHS 14BGIA20030027 American Heart Association-American Stroke Association R01 HL107594 NHLBI NIH HHS 16337 Cancer Research UK K12 GM068524 NIGMS NIH HHS K08 CA193982 NCI NIH HHS K02 AG042095 NIA NIH HHS P01 DK098108 NIDDK NIH HHS P30 ES006694 NIEHS NIH HHS R01 AG020197 NIA NIH HHS R01 HL071158 NHLBI NIH HHS GM053396 NIGMS NIH HHS BBS/E/B/000C0413 Biotechnology and Biological Sciences Research Council R01 GM097355 NIGMS NIH HHS P01 CA108671 NCI NIH HHS R01 HL130230 NHLBI NIH HHS R01 DK079879 NIDDK NIH HHS 16466 Cancer Research UK I01 BX002363 BLRD VA P42 ES027723 NIEHS NIH HHS K08 CA164047 NCI NIH HHS R01 HL079669 NHLBI NIH HHS R01 AR042527 NIAMS NIH HHS R01 AA022601 NIAAA NIH HHS R01 EY026885 NEI NIH HHS R01 DK090115 NIDDK NIH HHS K-1202 Parkinson's UK K01 DK075386 NIDDK NIH HHS P30 CA010815 NCI NIH HHS R01 AR060837 NIAMS NIH HHS G0801936 Medical Research Council R01 HL077328 NHLBI NIH HHS R15 GM102846 NIGMS NIH HHS R01 NS073813 NINDS NIH HHS R01 NS076896 NINDS NIH HHS 11975 Cancer Research UK K01 AA019996 NIAAA NIH HHS R01 HL116329 NHLBI NIH HHS R01 DK033823 NIDDK NIH HHS R01 CA089121 NCI NIH HHS R00 DK094980 NIDDK NIH HHS NC/L000199/1 National Centre for the Replacement, Refinement and Reduction of Animals in Research R01 DK098331 NIDDK NIH HHS R01 NS091218 NINDS NIH HHS R01 GM096193 NIGMS NIH HHS R03 DK089010 NIDDK NIH HHS R01 AT005076 NCCIH NIH HHS R01 CA184137 NCI NIH HHS R01 EY024581 NEI NIH HHS R01 GM053396 NIGMS NIH HHS I01 RX000444 RRD VA R01 HL117233 NHLBI NIH HHS R21 DK075494 NIDDK NIH HHS R01 HL114697 NHLBI NIH HHS MC_UU_12022/6 Medical Research Council R01 EY009083 NEI NIH HHS R01 CA178394 NCI NIH HHS G12 MD007595 NIMHD NIH HHS 087518 Wellcome Trust R01 HL085629 NHLBI NIH HHS R01 HL117913 NHLBI NIH HHS R37 AG021904 NIA NIH HHS R00 AG042494 NIA NIH HHS P20 GM104934 NIGMS NIH HHS R01 AR062030 NIAMS NIH HHS R01 NS062792 NINDS NIH HHS P30 AG028740 NIA NIH HHS R01 HL059888 NHLBI NIH HHS P01 CA163200 NCI NIH HHS R01 EY028559 NEI NIH HHS R01 AG045223 NIA NIH HHS R21 DA029249 NIDA NIH HHS R56 DK037034 NIDDK NIH HHS R01 EY022633 NEI NIH HHS R15 CA151112 NCI NIH HHS MR/M019217/1 Medical Research Council R03 DK106344 NIDDK NIH HHS H-1201 Parkinson's UK R56 NS065789 NINDS NIH HHS R01 EY026979 NEI NIH HHS P20 GM103554 NIGMS NIH HHS R01 CA109182 NCI NIH HHS R01 CA184208 NCI NIH HHS K08 NS085324 NINDS NIH HHS R01 CA175120 NCI NIH HHS R01 AI146180 NIAID NIH HHS R01 CA193698 NCI NIH HHS F-1002 Parkinson's UK R01 CA122346 NCI NIH HHS R01 AI108906 NIAID NIH HHS 14-1328 Worldwide Cancer Research R37 AI042999 NIAID NIH HHS MC_UP_A500_1019 Medical Research Council R01 CA143811 NCI NIH HHS R01 AI137198 NIAID NIH HHS R01 DK100163 NIDDK NIH HHS P20 GM103492 NIGMS NIH HHS R01 EY015537 NEI NIH HHS 12918 Cancer Research UK MR/N004434/1 Medical Research Council P20 GM103652 NIGMS NIH HHS K22 CA181274 NCI NIH HHS R01 AI111935 NIAID NIH HHS K08 NS083739 NINDS NIH HHS MC_U105185860 Medical Research Council R03 NS087338 NINDS NIH HHS MC_U105170648 Medical Research Council P30 DK020541 NIDDK NIH HHS P30 DK020593 NIDDK NIH HHS I01 BX001746 BLRD VA R01 DK073336 NIDDK NIH HHS 16464 Cancer Research UK R01 NS075685 NINDS NIH HHS R01 NS057553 NINDS NIH HHS R01 NS089737 NINDS NIH HHS P30 ES023512 NIEHS NIH HHS 15816 Cancer Research UK T32 CA009686 NCI NIH HHS R01 EY027733 NEI NIH HHS R00 DK087928 NIDDK NIH HHS R01 HL056416 NHLBI NIH HHS R01 AA019954 NIAAA NIH HHS U54 HD090255 NICHD NIH HHS R01 HL130845 NHLBI NIH HHS R35 CA220446 NCI NIH HHS R01 AA021751 NIAAA NIH HHS R03 NS090939 NINDS NIH HHS R01 GM061766 NIGMS NIH HHS R01 NS085070 NINDS NIH HHS R01 AG026389 NIA NIH HHS R01 NS077239 NINDS NIH HHS 12825 Cancer Research UK 18974 Cancer Research UK P30 DK020579 NIDDK NIH HHS R01 DK062777 NIDDK NIH HHS R21 NS091928 NINDS NIH HHS R01 DK062092 NIDDK NIH HHS R01 GM060574 NIGMS NIH HHS I01 RX001477 RRD VA P30 DK020572 NIDDK NIH HHS R01 DK105118 NIDDK NIH HHS R01 HL130174 NHLBI NIH HHS R01 GM089919 NIGMS NIH HHS MR/M00869X/1 Medical Research Council G0601891 Medical Research Council R01 CA142862 NCI NIH HHS R01 CA149646 NCI NIH HHS R01 HL072166 NHLBI NIH HHS R01 HL098216 NHLBI NIH HHS R21 AR060444 NIAMS NIH HHS R01 EY005681 NEI NIH HHS R01 NS079697 NINDS NIH HHS 19276 Cancer Research UK R01 AG038664 NIA NIH HHS R01 AR064420 NIAMS NIH HHS R01 GM114840 NIGMS NIH HHS R01 EY025362 NEI NIH HHS G1002186 Medical Research Council 2014112 Doris Duke Charitable Foundation R15 AI119980 NIAID NIH HHS R00 AG048016 NIA NIH HHS MR/K019384/1 Medical Research Council R01 DK061498 NIDDK NIH HHS MR/L010933/1 Medical Research Council R01 DK107220 NIDDK NIH HHS R01 CA162405 NCI NIH HHS R01 EY010577 NEI NIH HHS 10SDG2600164 American Heart Association-American Stroke Association RF1 AG043517 NIA NIH HHS R01 AI092084 NIAID NIH HHS R01 GM117466 NIGMS NIH HHS P01 AG031782 NIA NIH HHS R21 AI113526 NIAID NIH HHS R01 CA130893 NCI NIH HHS R01 EY013434 NEI NIH HHS R01 CA129536 NCI NIH HHS R56 HL122580 NHLBI NIH HHS R01 GM101056 NIGMS NIH HHS R01 GM063075 NIGMS NIH HHS R01 AG031867 NIA NIH HHS P20 GM103625 NIGMS NIH HHS G1000089 Medical Research Council R01 NS078560 NINDS NIH HHS R01 AI104928 NIAID NIH HHS 15890 Cancer Research UK R01 AR059115 NIAMS NIH HHS R01 DK094652 NIDDK NIH HHS R01 DK095842 NIDDK NIH HHS Collapse
4	Short-term treatment of acute intestinal amoebiasis with ornidazole. Acta Trop 1980;37:266-70. [PMID: 6106366] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/18/2023] Abstract Collapse Key Words Collapse MESH Headings Acute Disease Dose-Response Relationship, Drug Drug Administration Schedule Drug Tolerance Dysentery, Amebic/drug therapy Humans Nitroimidazoles/therapeutic use Ornidazole/therapeutic use Collapse Grants Collapse
5	[Toxoplasmosis: serological survey in normal adults]. ANAIS DO INSTITUTO DE HIGIENE E MEDICINA TROPICAL 1975;3:257-60. [PMID: 1235035] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 12/26/2022] Abstract Collapse Key Words Collapse MESH Headings Adult Brazil Female Humans Male Serologic Tests Toxoplasmosis/diagnosis Toxoplasmosis/epidemiology Collapse Grants Collapse